For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
Senate Parliamentarian Eliminates Medicaid Reform Provisions, Leaving Costs/Problems Intact
The Senate’s parliamentarian has determined that many of the Medicaid provisions in the One Big Beautiful Bill cannot be passed with simple majority vote via…
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products for…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
The New York Post
Team Biden’s Extending the COVID Emergency Again — to Expand the Welfare State
It’s official. Despite President Biden’s recent admission that the pandemic is over, his team will extend the COVID-19 public health emergency through at least April…
The New York Post
Team Biden’s Latest Welfare Expansion: Medicaid Payments for Housing, Food, even Furniture
Co-authored by Dr. Joel Zinberg and Gary Alexander The latest front in the Biden administration’s crusade to bypass the congressional appropriations process and expand the…
National Review
The CDC’s Premature Childhood-Vaccine Decision
The Centers for Disease Control and Prevention has proven once again how tone-deaf it is. The CDC’s independent Advisory Committee on Immunization Practices (ACIP) voted 15–0…
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …
Blog
One Year on, FDA Sodium Guidance Still Wanting
It is the one year anniversary of the Food and Drug Administration’s (FDA) Guidance for Industry setting out goals to reduce sodium content in…
